Incidence of Cardiac Implantable Electronic Device Complications in Patients With Left Ventricular Assist Devices

• Published in: JACC. Clinical electrophysiology 2021-04, Vol.7 (4), p.494-501
• Main Authors: Gilge, Jasen L., Sbircea, Nicole, Tong, Michael Z., Bauza, Karolis, Cantillon, Daniel J., Srivastava, Ajay, Khedraki, Rola, Sheikh, Farooq H., Ahmed, Sara, Herr, Jared, Hsiao, Stephanie, Patel, Parin J., D’Souza, Benjamin, Ravichandran, Ashwin K.
• Format: Article
• Language: English
• Subjects: cardiac implantable electronic device; congestive heart failure; left ventricular assist device; ventricular tachycardia
• ISSN: 2405-500X; 2405-5018
• DOI: 10.1016/j.jacep.2020.09.008

The objective of this study was to describe the risk of cardiac implantable electronic devices (CIEDs) complications in patients with left ventricular assist devices (LVADs). Patients with LVADs are predisposed to ventricular arrhythmias and frequently have CIEDs before receiving their LVAD. However, the role of CIED procedures such as generator changes (GC) are unclear in this population, given the potential complications of bleeding and infection. This was a retrospective, multicenter study from January 1, 2012, to September 30, 2018. All patients with LVADs were screened and those who had a CIED GC, implantation, or revision were included in the study and followed until December 31, 2018. A total of 179 patients across 6 centers had a CIED procedure after LVAD implantation. The mean age was 59.5 ± 13.4, with the cohort comprising mostly men (78%), destination LVAD therapy (53.8%), and GC (66%). The 30-day primary composite endpoint of hematoma or device infection occurred in 34 (19%) patients. The secondary endpoints of rehospitalization within 30 days and appropriate device therapy during follow-up occurred in 40 (22%) and 42 (24%) patients respectively. Of the 126 patients without previous device therapy, 14.3% received appropriate therapy during follow-up. In this large, multicenter cohort, we report the incidence of complications for CIED procedures in the LVAD population; specifically, LVAD patients are at increased risk of pocket hematomas, without downstream risk of infection, and do experience a high rate of appropriate device therapies. [Display omitted]